Source BioScience invest in digital pathology platform to enhance the outsourced histopathology service solution provided to the NHS and private healthcare.
Driving down turnaround times (TATs), to enable a more rapid diagnosis and treatment of patients is the key philosophy of Source BioScience.
As a leading provider of...




















